
- /
- Supported exchanges
- / US
- / CAH.NYSE
Cardinal Health Inc (CAH NYSE) stock market data APIs
Cardinal Health Inc Financial Data Overview
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Cardinal Health Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Cardinal Health Inc data using free add-ons & libraries
Get Cardinal Health Inc Fundamental Data
Cardinal Health Inc Fundamental data includes:
- Net Revenue: 222 578 M
- EBITDA: 3 273 M
- Earnings Per Share: 6
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: 2.03
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cardinal Health Inc News

CVS Expands Its Nationwide Care Network With Rite Aid Acquisition
CVS Health’s CVS Pharmacy unit has officially completed the acquisition of select Rite Aid assets across the United States. The deal adds 63 former Rite Aid and Bartell Drugs stores in Idaho, Oregon...


Why Cardinal Health’s (CAH) Diversified Operations Make it a Must-Buy Dividend Stock for Long-Term Investors
Cardinal Health, Inc. (NYSE:CAH) is included among the 12 Must-Buy Dividend Stocks to Invest in.Why Cardinal Health’s (CAH) Diversified Operations Make it a Must-Buy Dividend Stock for Long-Term Inv...

Cardinal Health (CAH): Is There More Upside After Major Expansion and New Product Launches?
Cardinal Health (CAH) is stepping up its growth strategy with two major developments. The company is building a new, advanced distribution center in Indianapolis and rolling out its Kendall SCD SmartF...

Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US
DETROIT, October 16, 2025--(BUSINESS WIRE)--Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.